KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Shares Issued (2020 - 2024)

AbCellera Biologics (ABCL) has disclosed Shares Issued for 4 consecutive years, with $227000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Shares Issued fell 11.33% year-over-year to $227000.0, compared with a TTM value of $1.8 million through Sep 2024, down 36.99%, and an annual FY2021 reading of $4.6 million, down 99.12% over the prior year.
  • Shares Issued was $227000.0 for Q3 2024 at AbCellera Biologics, down from $461000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $521.9 million in Q4 2020 and bottomed at $124000.0 in Q1 2020.
  • Average Shares Issued over 4 years is $37.9 million, with a median of $475500.0 recorded in 2023.
  • Peak annual rise in Shares Issued hit 1246.46% in 2021, while the deepest fall reached 99.65% in 2021.
  • Year by year, Shares Issued stood at $521.9 million in 2020, then crashed by 99.65% to $1.8 million in 2021, then crashed by 86.04% to $256000.0 in 2023, then dropped by 11.33% to $227000.0 in 2024.
  • Business Quant data shows Shares Issued for ABCL at $227000.0 in Q3 2024, $461000.0 in Q2 2024, and $892000.0 in Q1 2024.